Upregulation of arginase by H2O2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 26, Issue 9, 2006, Pages 2035-2042

  Thengchaisri, Naris ^a,c   Hein, Travis W ^a   Wang, Wei ^a   Xu, Xin ^a   Li, Zhenbo ^a   Fossum, Theresa W ^b   Kuo, Lih ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c KASETSART UNIVERSITY   (Thailand)

Author keywords

Endothelium; Free radicals; Hydrogen peroxide; Nitric oxide

Indexed keywords

ADENOSINE; ARACHIDONIC ACID; ARGINASE; ARGININE; BRADYKININ; CYTOCHROME P450; CYTOCHROME P450 OXYGENASE; DEFEROXAMINE; EFLORNITHINE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; IONOMYCIN; N(G) HYDROXYARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; ENDOTHELIAL NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; SCAVENGER;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL TONE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; ENDOTHELIUM CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VASODILATATION; WESTERN BLOTTING; ANIMAL; CORONARY BLOOD VESSEL; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; UPREGULATION; VASCULAR ENDOTHELIUM;

ANIMALS; ARGINASE; ARGININE; ARTERIOLES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDANTS; REACTIVE OXYGEN SPECIES; SWINE; UP-REGULATION; VASODILATION;

EID: 33747429424     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000233334.24805.62     Document Type: Article

References (64)

1. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol. 2000;279:L1005-L1028.
2. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med. 2000;28:463-499.
3. Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem. 2001;11:173-186.
4. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH, Skatchkov M, Heitzer T, Stasch JP, Griendling KK, Harrison DG, Bohm M, Meinertz T, Munzel T. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation. 1999;99:2027-2033.
5. Wu R, Millette E, Wu L, de Champlain J. Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats. J Hypertens. 2001;19:741-748.
6. Guerci B, Bohme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab. 2001;27:436-447.
7. Gross GJ, O'Rourke ST, Pelc LR, Warltier DC. Myocardial and endothelial dysfunction after multiple, brief coronary occlusions: role of oxygen radicals. Am J Physiol. 1992;263:H1703-H1709.
8. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.
9. Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role? Am J Physiol Heart Circ Physiol. 2001;281:H981-H986.
10. Walia M, Sormaz L, Samson SE, Lee RM, Grover AK. Effects of hydrogen peroxide on pig coronary artery endothelium. Eur J Pharmacol. 2000;400:249-253.
11. 2 causes endothelial barrier dysfunction without disrupting the arginine-nitric oxide pathway. Am J Physiol. 1998;274:L508-L516.
12. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res. 2000;86:347-354.
13. Wu G, Meininger CJ. Impaired arginine metabolism and NO synthesis in coronary endothelial cells of the spontaneously diabetic BB rat. Am J Physiol. 1995;269:H1312-H1318.
14. Zhang C, Hein TW, Wang W, Chang CI, Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J. 2001;15:1264-1266.
15. G-hydroxy-L-arginine during high-output NO production. Am J Physiol. 1996;271:H1988-H1998.
16. Chicoine LG, Paffett ML, Young TL, Nelin LD. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;287:L60-L68.
17. Chang CI, Liao JC, Kuo L. Arginase modulates nitric oxide production in activated macrophages. Am J Physiol. 1998;274:H342-H348.
18. Waddington SN, Mosley K, Cook HT, Tam FW, Cattell V. Arginase AI is upregulated in acute immune complex-induced inflammation. Biochem Biophys Res Commun. 1998;247:84-87.
19. Abd-El-Aleem SA, Ferguson MW, Appleton I, Kairsingh S, Jude EB, Jones K, McCollum CN, Ireland GW. Expression of nitric oxide synthase isoforms and arginase in normal human skin and chronic venous leg ulcers. J Pathol. 2000;191:434-442.
20. Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V. Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol. 2003;162:203-211.
21. Kuo L, Davis MJ, Cannon MS, Chilian WM. Pathophysiological consequences of atherosclerosis extend into the coronary microcirculation. Restoration of endothelium-dependent responses by L-arginine. Circ Res. 1992;70:465-476.
22. ATP channels. Circ Res. 1999;85:634-642.
23. Hein TW, Kuo L. LDLs impair vasomotor function of the coronary microcirculation: role of superoxide anions. Circ Res. 1998;83:404-414.
24. Hein TW, Liao JC, Kuo L. oxLDL specifically impairs endothelium- dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol. 2000;278:H175-H183.
25. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am J Physiol Heart Circ Physiol. 2003;285:H2255-H2263.
26. 2 and endothelium-dependent cerebral arteriolar dilation. Implications for the identity of endothelium-derived relaxing factor generated by acetylcholine. Hypertension. 1990;16:162-169.
27. Karasu C. Time course of changes in endothelium-dependent and -independent relaxation of chronically diabetic aorta: role of reactive oxygen species. Eur J Pharmacol. 2000;392:163-173.
28. Tenu JP, Lepoivre M, Moali C, Brollo M, Mansuy D, Boucher JL. Effects of the new arginase inhibitor N(omega)-hydroxy-nor-L-arginine on NO synthase activity in murine macrophages. Nitric Oxide. 1999;3:427-438.
29. Hein TW, Wang W, Zoghi B, Muthuchamy M, Kuo L. Functional and molecular characterization of receptor subtypes mediating coronary microvascular dilation to adenosine. J Mol Cell Cardiol. 2001;33:271-282.
30. Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res. 2003;92:e31-e40.
31. Ca channel activity. Am J Physiol Heart Circ Physiol. 1998;275:H1283-H1289.
32. Grover AK, Samson SE, Misquitta CM, Elmoselhi AB. Effects of peroxide on contractility of coronary artery rings of different sizes. Mol Cell Biochem. 1999;194:159-164.
33. Babbs CF, Cregor MD, Badylak SF. Histochemical demonstration of endothelial superoxide and hydrogen peroxide generation in ischaemic and reoxygenated rat tissues. Cardiovasc Res. 1992;26:593-602.
34. Skepper JN, Pierson RN, 3rd, Young VK, Rees JA, Powell JM, Navaratnam V, Cary NR, Tew DN, Bacon PJ, Wallwork J, White DJ, Menon DK. Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion. Microsc Res Tech. 1998;42:369-385.
35. Lacy F, O'Connor DT, Schmid-Schonbein GW. Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens. 1998;16:291-303.
36. Deskur E, Przywarska I, Dylewicz P, Szczesniak L, Rychlewski T, Wilk M, Wysocki H. Exercise-induced increase in hydrogen peroxide plasma levels is diminished by endurance training after myocardial infarction. Int J Cardiol. 1998;67:219-224.
37. Varma SD, Devamanoharan PS. Hydrogen peroxide in human blood. Free Radic Res Commun. 1991;14:125-131.
38. 2) plasma level and malondialdehyde serum concentration. Int J Cardiol. 1996;56:137-143.
39. Kazmierczak M, Wysocki H, Wykretowicz A, Minczykowski A. Estimation of hydrogen peroxide plasma levels in patients evaluated for coronary heart disease using dipyridamole infusion followed by SPECT. Coron Artery Dis. 1995;6:65-69.
40. Halliwell B, Clement MV, Long LH. Hydrogen peroxide in the human body. FEBS Lett. 2000;486:10-13.
41. 2-mediated endothelial cell injury. Vascul Pharmacol. 2003;40:109-118.
42. Pearse DB, Shimoda LA, Verin AD, Bogatcheva N, Moon C, Ronnett GV, Welsh LE, Becker PM. Effect of cGMP on lung microvascular endothelial barrier dysfunction following hydrogen peroxide. Endothelium. 2003;10:309-317.
43. Suhara T, Fukuo K, Sugimoto T, Morimoto S, Nakahashi T, Hata S, Shimizu M, Ogihara T. Hydrogen peroxide induces up-regulation of Fas in human endothelial cells. J Immunol. 1998;160:4042-4047.
44. Liou JY, Lee S, Ghelani D, Matijevic-Aleksic N, Wu KK. Protection of endothelial survival by peroxisome proliferator-activated receptor-{delta} mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol. 2006. Epub ahead of print.
45. Weiss SJ, Young J, LoBuglio AF, Slivka A, Nimeh NF. Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells. J Clin Invest. 1981;68:714-721.
46. Suttorp N, Simon LM. Lung cell oxidant injury. Enhancement of polymorphonuclear leukocyte-mediated cytotoxicity in lung cells exposed to sustained in vitro hyperoxia. J Clin Invest. 1982;70:342-350.
47. Grover AK, Hui J, Samson SE. Catalase activity in coronary artery endothelium protects smooth muscle against peroxide damage. Eur J Pharmacol. 2000;387:87-91.
48. Saheki T, Sato Y, Takada S, Katsunuma T. Regulation of urea synthesis in rat liver. Inhibition of urea synthesis by L-norvaline. J Biochem. 1979;86:745-750.
49. Aminlari M, Vaseghi T. Arginase distribution in tissues of domestic animals. Comp Biochem Physiol B. 1992;103:385-389.
50. Moali C, Brollo M, Custot J, Sari MA, Boucher JL, Stuehr DJ, Mansuy D. Recognition of alpha-amino acids bearing various C=NOH functions by nitric oxide synthase and arginase involves very different structural determinants. Biochemistry. 2000;39:8208-8218.
51. Yang BC, Phillips MI, Ambuehl PE, Shen LP, Mehta P, Mehta JL. Increase in angiotensin II type 1 receptor expression immediately after ischemia-reperfusion in isolated rat hearts. Circulation. 1997;96:922-926.
52. Xu Y, Clanachan AS, Jugdutt BI. Enhanced expression of angiotensin II type 2 receptor, inositol 1,4, 5-trisphosphate receptor, and protein kinase cepsilon during cardioprotection induced by angiotensin II type 2 receptor blockade. Hypertension. 2000;36:506-510.
53. Morawietz H, Ma YH, Vives F, Wilson E, Sukhatme VP, Holtz J, Ives HE. Rapid induction and translocation of Egr-1 in response to mechanical strain in vascular smooth muscle cells. Circ Res. 1999;84:678-687.
54. Ling S, Dai A, Ma YH, Wilson E, Chatterjee K, Ives HE, Sudhir K. Matrix-dependent gene expression of egr-1 and PDGF A regulate angiotensin II-induced proliferation in human vascular smooth muscle cells. Hypertension. 1999;34:1141-1146.
55. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, Humphrey JD, Kuo L. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44:935-943.
56. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J. 2003;17:2328-2330.
57. Carter WO, Narayanan PK, Robinson JP. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol. 1994;55:253-258.
58. Zhang DX, Yi FX, Zou AP, Li PL. Role of ceramide in TNF-alpha-induced impairment of endothelium-dependent vasorelaxation in coronary arteries. Am J Physiol Heart Circ Physiol. 2002;283:H1785-H1794.
59. Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V, Shi X. Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med. 2003;34:1333-1342.
60. Ramesh G, Reeves WB. p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice. Am J Physiol Renal Physiol. 2005;289:F166-F174.
61. Kim BY, Han MJ, Chung AS. Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells. Free Radic Biol Med. 2001;30:686-698.
62. Tan CM, Xenoyannis S, Feldman RD. Oxidant stress enhances adenylyl cyclase activation. Circ Res. 1995;77:710-717.
63. Chang CI, Zoghi B, Liao JC, Kuo L. The involvement of tyrosine kinases, cyclic AMP/protein kinase A, and p38 mitogen-activated protein kinase in IL-13-mediated arginase I induction in macrophages: its implications in IL-13-inhibited nitric oxide production. J Immunol. 2000;165:2134-2141.
64. Wei LH, Jacobs AT, Morris SM, Jr., Ignarro LJ. IL-4 and IL-13 upregulate arginase I expression by cAMP and JAK/STAT6 pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol. 2000;279:C248-C256.